Modus Therapeutics AB - Company Review
Modus Therapeutics AB - Company ReviewSummary
Modus Therapeutics AB (Modus Therapeutics), a subsidiary of Modus Therapeutics Holding AB, is a drug development company which focuses on the development of new drug for the treatment of sickle cell disease (SCD). Its lead candidate sevuparin, a proprietary polysaccharide drug has the ability to restore blood flow and prevent further microvascular obstruction in patients of sickle cell disease. The company also develops sevuparin for the management of acute vaso-occlusive crises (VOCs) and treatment of severe malaria. The investors of the company include KDev Investments AB, Praktikerinvest PE AB, Karolinska Development AB and Rosetta Capital Ltd. Modus Therapeutics is headquartered in Stockholm, Sweden.
This comprehensive company report of Modus Therapeutics AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.